Lemuteporfin
- Generic Name
- Lemuteporfin
- Drug Type
- Small Molecule
- Chemical Formula
- C44H48N4O10
- CAS Number
- 215808-49-4
- Unique Ingredient Identifier
- EZ109VJ012
Overview
Lemuteporfin, under development by QLT Incorporated, is a benzoporphyrin-derived chlorin-like photosensitizer. It is intended for the treatment of beign prostatic hyperplasia.
Background
Lemuteporfin, under development by QLT Incorporated, is a benzoporphyrin-derived chlorin-like photosensitizer. It is intended for the treatment of beign prostatic hyperplasia.
Indication
Intended for the treatment of benign prostatic hyperplasia and prostrate disorders.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath